HOXD13 and ankylosing spondylitis: Notably, sPD-1 has been identified as a pro-inflammatory factor that sustains abnormal T cell activation by disrupting PD-1/PD-L1 signaling, thereby increasing disease activity of SLE, IgAN and ankylosing spondylitis (AS) (20, 24, 35).